Log in
Enquire now
‌

US Patent 10149820 Compositions and methods for treating pterygium

Patent 10149820 was granted and assigned to CLOUDBREAK THERAPEUTICS LLC on December, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
0
Date Filed
May 29, 2018
0
Date of Patent
December 11, 2018
0
Patent Applicant
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
0
Patent Application Number
15991698
0
Patent Citations Received
‌
US Patent 11911379 Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization
0
‌
US Patent 10688092 Compositions and methods of using nintedanib for improving glaucoma surgery success
‌
US Patent 10980741 Compositions and methods for treating pterygium recurrence
0
‌
US Patent 11246864 Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization
Patent Inventor Names
Jinsong Ni
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10149820
0
Patent Primary Examiner
‌
Theodore R West
0

Find more entities like US Patent 10149820 Compositions and methods for treating pterygium

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.